Bringing the fundamentals into focus…
Back to Pacira BioSciences, Inc.
How Pacira BioSciences, Inc. stacks up
PCRX · against 446 other Healthcare companies of similar size
Profitability
42/ 100
Below the middle of the pack.
Ranked #271 of 447 · scores higher than 38% of peers
Bars: peers in each 10-point band of the profitability score52 peers with a profitability score of 40–49, including PCRX · Click a bar to see the companies
Why profitability scores 42?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- a thinner operating margin: weaker than 62% of peers. Operating margin: 2.7% vs peer median 7.1%
- Return on invested capital is close to the peer norm. Return on invested capital: 1.9% vs peer median 4.7%
- Return on assets is close to the peer norm. Return on assets: 1.2% vs peer median 1.7%
Metric by metric
Position: dot = PCRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 422 reported | 1.9% | 5.4% | 38% | 33% | |
| Operating marginHigher is better · 421 reported | 2.7% | 7.1% | 38% | 33% | |
| Return on assetsHigher is better · 433 reported | 1.2% | 1.9% | 44% | 33% | |
| Return on equityHigher is better · 417 reported | 2.0% | 3.4% | 44% | Context only | |
| Gross marginHigher is better · 463 reported | 79.2% | 47.7% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around PCRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 271 | 7.1B CNY (≈$988M) | 42 | 46 | |
| 271 | 5.9B CNY (≈$824M) | 42 | 26 | |
| 271 | 1.1B USD | 42 | 43 | |
| 271 | 1.3B CHF (≈$1.5B) | 42 | 48 | |
| 271 | 1.5B USD | 42 | 59 | |
| 278 | 8.9B CNY (≈$1.2B) | 41 | 42 | |
| 278 | 1.2B USD | 41 | 42 | |
| 278 | 1.1B CAD (≈$807M) | 41 | 60 | |
| 281 | 5.9B HKD (≈$757M) | 40 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score